Shares of Summit Therapeutics (NASDAQ:SMMT) ended five straight sessions of gains on Friday as the stock lost ~35%, ...

Cancer drugs that received accelerated approval from the FDA gained regular approval significantly faster if their ...

Penpulimab is approved for multiple indications in China, but this marks the first US approval for the novel monoclonal ...

Waksal, who is not a medical doctor, imported the veterinary drug along with other “unapproved ingredients” from Colombia.

Akeso, a Chinese biotech that made headlines for beating Merck’s Keytruda in a head-to-head trial, won approval in China this week for the therapy, a company spokesperson confirmed to STAT. New data ...

Following a positive readout for its closely watched PD-1xVEGF bispecific ivonescimab, Akeso has won the FDA’s go-ahead for ...

Patients will likely eventually see higher prices and drug shortages under President Trump's plan to assess tariffs on ...

Gilead Sciences on Thursday reported a first-quarter profit, but revenue was flat, as higher sales of drugs for HIV and liver ...

The FDA's move stops short of the outright ban that had been floated for in Kennedy's "Make America Healthy Again" platform ...

The frequency of high blood glucose among patients receiving PI3K/Akt inhibitors to treat breast cancer has some oncologists ...

A quick spray of medication might seem like an easy way to get thicker hair, but some people say one sold online has left ...